<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Case Study: Superluminal Medicines | Osprey Intel</title>
  <style>
    :root{
      --bg:#0b1220;--panel:#121a2b;--muted:#30415f;--card:#0f1626;--text:#ebf2ff;--accent:#4cc9f0;--accent-2:#a3ffb0;--warn:#ffd166;
      --shadow:0 10px 30px rgba(0,0,0,.25);
      --radius:16px;
    }
    *{box-sizing:border-box}
    html,body{height:100%}
    body{margin:0;background:linear-gradient(180deg,var(--bg),#0a0f1a);color:var(--text);font-family:Inter,ui-sans-serif,system-ui,-apple-system,Segoe UI,Roboto,Helvetica,Arial;line-height:1.55}
    a{color:var(--accent);text-decoration:none}
    a:hover{color:#5ef0c4;}
    h1, h2, h3, h4 { letter-spacing: -0.02em; }
    .app{display:grid;grid-template-columns:280px 1fr;min-height:100vh}
    aside{background:var(--panel);padding:20px;border-right:1px solid #1f2b44}
    main{padding:0}
    .main-content{padding: 28px 32px;}
    .brand{display:flex;align-items:center;gap:12px;margin-bottom:16px}
    .logo{width:36px;height:36px;border-radius:10px;background:linear-gradient(135deg,var(--accent),#5ef0c4)}
    h1{font-size:22px;margin:0}
    .subtle{color:#b7c3d7;font-size:12px}
    nav ul{list-style:none;padding:0;margin:10px 0 0}
    nav li{margin:4px 0}
    .nav-link{display:flex;align-items:center;gap:10px;padding:10px 12px;border-radius:10px;color:#cfe3ff; font-size: 14px; transition: background-color 0.2s ease;}
    .nav-link.active, .nav-link:hover{background:#0a1324; color: white;}
    .section{margin-bottom:32px}
    .header{background:linear-gradient(180deg,rgba(11,18,32,.98),rgba(11,18,32,.85));backdrop-filter:blur(8px);z-index:20;padding:14px 24px;border-bottom:1px solid #17233a;display:flex;align-items:center;gap:14px}
    .header h2{margin:0;font-size:18px}
    .card{background:linear-gradient(180deg,var(--card),#0a0f1a);border:1px solid #1b2742;border-radius:var(--radius);padding:20px;box-shadow:var(--shadow)}
    .card h3{margin:0 0 8px;font-size:18px; color: var(--accent-2);}
    .muted{color:#9fb0cc}
    .deliverable-link{display:block;padding:12px 16px;border:1px dashed #25406a;border-radius:12px;color:#bcd0f3; margin-top: 8px; transition: background-color 0.2s;}
    .deliverable-link:hover{background:#0a1324}
  </style>
</head>
<body>
<div class="app">
  <aside>
    <div class="brand">
      <div class="logo" aria-hidden="true"></div>
      <div>
        <h1>Osprey Intel</h1>
        <div class="subtle">Case Studies</div>
      </div>
    </div>
    <nav>
      <ul>
        <li><a class="nav-link" href="./">← Back to Profile</a></li>
      </ul>
    </nav>
  </aside>
  <main>
    <header class="header">
      <h2>Case Study: Superluminal Medicines</h2>
    </header>
    <div class="main-content">
      <section class="section">
        <div class="card">
          <h3>Client Background</h3>
          <p class="muted">Superluminal Medicines is a biotechnology company focused on the development of novel therapeutics targeting G-protein-coupled receptors (GPCRs). As a key player in a competitive field, they require precise, up-to-date market intelligence to inform their corporate strategy and business development activities.</p>
        </div>
      </section>
      <section class="section">
        <div class="card">
          <h3>Project Details</h3>
          <p class="muted">Osprey Intel was engaged to conduct a rapid competitor analysis and build a comprehensive database of GPCR-related licensing transactions. This pro bono pilot project validated our rapid-response capabilities for corporate strategy teams. The goal was to provide Superluminal's board with actionable benchmarks and strategic insights on a tight deadline for an upcoming investor meeting, focusing on stage-gated valuation analysis and identifying key market trends.</p>
        </div>
      </section>
      <section class="section">
        <div class="card">
          <h3>Clickable Deliverables (Sanitized)</h3>
          <p class="muted">The following artifacts were delivered to provide a comprehensive view of the GPCR licensing landscape.</p>
          <a href="artifacts/GLP-1 and GPCR Deep Dive.pdf" class="deliverable-link" target="_blank">GLP-1 and GPCR Deep Dive →</a>
          <a href="artifacts/GPCR Licensing One‑Pager.html" class="deliverable-link" target="_blank">Stage-gated Licensing Analysis (Cortellis Data)**removed from the public site at client request.** →</a>
        </div>
      </section>
       <section class="section">
        <div class="card">
          <h3>Sources Cited</h3>
          <p class="muted">This engagement synthesized data from a wide range of institutional-grade sources, including Cortellis Intelligence Database, SEC filings (8-K, 10-K), official company press releases, PitchBook, and leading industry publications like Nature Reviews Drug Discovery to ensure a robust and verifiable analysis.</p>
        </div>
      </section>
    </div>
  </main>
</div>
</body>

</html>


